Verichem Releases Ready-To-Use HDL/LDL Calibration Verification Kit
Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
Verichem’s HDL Cholesterol Verifier Kit contains HDL and LDL cholesterol and other lipid components from human serum free of potential interfering substances.
In a recent clinical trial conducted in collaboration with the University Hospital of Zurich, the Ava bracelet captured physiological changes known to occur in early pregnancy.
Abridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP's well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MoreLaboratory testing plays a vital role in keeping tabs on aging women.
Read MoreLabs play a vital role in testing women for heart disease.
Read MoreMid America Clinical Laboratories is a joint venture clinical laboratory owned by Quest Diagnostics, Community Health Network, St. Vincent Health, and CoLab.
Read MoreStudies have found new diagnostic tests in development for heart conditions are expected to help clinicians reduce time to heart attack treatment and potentially improve the way heart attacks are diagnosed in women.
Read MoreBeckman Coulter Inc, Orange County, Calif, announced research results that demonstrated that elevated levels of pregnancy associated plasma protein-A (PAPP-A), as measured by the companys investigative test cPAPP-A, can predict risk of imminent heart attack or death in patients with non-ST segment elevation (NSTE) Acute Coronary Syndrome (ACS).
Read MoreResearchers have found that high levels of triglycerides (blood fats) are the strongest risk factor for the most common type of stroke in older women.
Read MoreResearchers concluded that the ratio of apoA1 to remnant lipoproteins is a strong predictor of short- and intermediate-term heart disease risk among women over 50 years of age.
Read MoreThe VAP Cholesterol Testdeveloped by Atherotech Diagnostics Labalong with diet, exercise, and the right medication, is changing how doctors approach Polycystic Ovarian Syndrome.
Read MoreCelera Corporation announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.
Read MoreNew research shows a long-term benefit in screening people for CRP, a marker for inflammation, even if they have normal levels of bad cholesterol, because of increased long-term risk for heart attack, stroke and death.
Read MoreNew technologies produce more clinically useful information
Read MoreLong-term low-intensity warfarin therapy found highly effective in preventing recurrent VTE A new study led by Paul M. Ridker, M.D. of Brigham and Women’s Hospital and Harvard Medical School, has found that long-term, low-intensity warfarin t
Read MoreSponsored by an educational grant from the Diagnostic Division of Bayer Corp
Read More